Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia.
Wang ZhaoZhifeng ChengXianyou JiZhaohui PeiKeping YangZhouqing HuangYanqing WuGaopin WangMinghui WangYi ZhaoXuelian BaiShuiping ZhaoPublished in: Nutrition, metabolism, and cardiovascular diseases : NMCD (2024)
CTR20220027; January 11, 2022; http://www.chinadrugtrials.org.cn/index.html.